Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 215
- 主要终点
- Overall Patient Satisfaction
研究概览
简要总结
The purpose of this study is to evaluate patient perceptions of olopatadine 0.2% dosed once daily in patients previously treated with twice-daily, topical, ocular, anti-allergy medications.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •12 years of age or older.
- •History (within the past 24 months) of allergic conjunctivitis.
- •Active signs and symptoms of ocular allergies.
- •Ocular health within normal limits, as determined by the investigator or subinvestigator.
- •Willing to avoid contact lens wear each study visit immediately prior to study medication instillation and for 10 minutes after instillation of study drug.
- •Other protocol-defined inclusion criteria may apply.
排除标准
- •Contraindications or hypersensitivity to study medication or its components.
- •One sighted eye or not correctable to 0.6 logMAR or better in both eyes at the screening visit.
- •Known history of recurrent corneal erosion syndrome.
- •Ocular trauma or surgical intervention within 6 months prior to Visit
- •Participation in any other investigational study within 30 days before Visit
- •Pregnant or nursing.
- •Other protocol-defined exclusion criteria may apply.
研究组 & 干预措施
Olopatadine 0.2%
1 drop self-administered in each eye once daily in the morning for 7 days
干预措施: Olopatadine hydrochloride ophthalmic solution, 0.2% (Pataday®) (Drug)
结局指标
主要结局
Overall Patient Satisfaction
时间窗: Day 7
Overall satisfaction was assessed by the patient on a questionnaire. The patient was instructed to select a single response to the statement, "Overall, how satisfied were you with olopatadine 0.2%?" A 5-point scale was used: very satisfied, satisfied, undecided, dissatisfied, very dissatisfied. Results are reported as the percentage of patients who responded, "very satisfied" or "satisfied."
次要结局
未报告次要终点